nodes	percent_of_prediction	percent_of_DWPC	metapath
Fenofibrate—PPARA—prostate cancer	0.323	0.829	CbGaD
Fenofibrate—CYP3A4—prostate cancer	0.0668	0.171	CbGaD
Fenofibrate—CYP2C8—Nilutamide—prostate cancer	0.0371	0.104	CbGbCtD
Fenofibrate—CYP2C8—Abiraterone—prostate cancer	0.0307	0.0859	CbGbCtD
Fenofibrate—CYP3A4—Estradiol valerate/Dienogest—prostate cancer	0.0286	0.08	CbGbCtD
Fenofibrate—CYP2C9—Nilutamide—prostate cancer	0.0259	0.0723	CbGbCtD
Fenofibrate—CYP2C9—Bicalutamide—prostate cancer	0.0259	0.0723	CbGbCtD
Fenofibrate—CYP2C8—Cabazitaxel—prostate cancer	0.0227	0.0635	CbGbCtD
Fenofibrate—CYP2C8—Ethinyl Estradiol—prostate cancer	0.0198	0.0554	CbGbCtD
Fenofibrate—CYP2C9—Estrone—prostate cancer	0.0155	0.0433	CbGbCtD
Fenofibrate—CYP3A4—Bicalutamide—prostate cancer	0.015	0.042	CbGbCtD
Fenofibrate—CYP3A4—Estramustine—prostate cancer	0.014	0.0391	CbGbCtD
Fenofibrate—CYP2C8—Estradiol—prostate cancer	0.0128	0.0357	CbGbCtD
Fenofibrate—CYP3A4—Flutamide—prostate cancer	0.0125	0.0348	CbGbCtD
Fenofibrate—CYP3A4—Abiraterone—prostate cancer	0.0125	0.0348	CbGbCtD
Fenofibrate—CYP2C9—Capecitabine—prostate cancer	0.0117	0.0328	CbGbCtD
Fenofibrate—CYP3A4—Cabazitaxel—prostate cancer	0.00922	0.0258	CbGbCtD
Fenofibrate—CYP3A4—Estrone—prostate cancer	0.00901	0.0252	CbGbCtD
Fenofibrate—CYP2C9—Estradiol—prostate cancer	0.0089	0.0249	CbGbCtD
Fenofibrate—CYP2C8—Etoposide—prostate cancer	0.00834	0.0233	CbGbCtD
Fenofibrate—CYP3A4—Ethinyl Estradiol—prostate cancer	0.00803	0.0225	CbGbCtD
Fenofibrate—CYP3A4—Conjugated Estrogens—prostate cancer	0.0059	0.0165	CbGbCtD
Fenofibrate—CYP3A4—Mitoxantrone—prostate cancer	0.00536	0.015	CbGbCtD
Fenofibrate—CYP3A4—Estradiol—prostate cancer	0.00518	0.0145	CbGbCtD
Fenofibrate—CYP3A4—Prednisone—prostate cancer	0.00445	0.0124	CbGbCtD
Fenofibrate—CYP3A4—Etoposide—prostate cancer	0.00338	0.00945	CbGbCtD
Fenofibrate—CYP3A4—Docetaxel—prostate cancer	0.00309	0.00864	CbGbCtD
Fenofibrate—CYP3A4—Doxorubicin—prostate cancer	0.00231	0.00644	CbGbCtD
Fenofibrate—PPARA—prostate gland—prostate cancer	0.0015	0.188	CbGeAlD
Fenofibrate—CYP2C9—urine—prostate cancer	0.00135	0.168	CbGeAlD
Fenofibrate—PPARA—epithelium—prostate cancer	0.00111	0.138	CbGeAlD
Fenofibrate—CYP3A4—urine—prostate cancer	0.00103	0.128	CbGeAlD
Fenofibrate—PPARA—renal system—prostate cancer	0.00103	0.128	CbGeAlD
Fenofibrate—Clofibrate—GSTA2—prostate cancer	0.000746	0.193	CrCbGaD
Fenofibrate—PPARA—testis—prostate cancer	0.000663	0.0826	CbGeAlD
Fenofibrate—Clofibrate—PPARA—prostate cancer	0.000591	0.153	CrCbGaD
Fenofibrate—PPARA—lymph node—prostate cancer	0.000481	0.0599	CbGeAlD
Fenofibrate—Bezafibrate—PPARA—prostate cancer	0.000431	0.112	CrCbGaD
Fenofibrate—CYP2C8—renal system—prostate cancer	0.000372	0.0463	CbGeAlD
Fenofibrate—Indomethacin—AKR1C3—prostate cancer	0.000369	0.0957	CrCbGaD
Fenofibrate—Indomethacin—PPARA—prostate cancer	0.00032	0.0829	CrCbGaD
Fenofibrate—Clofibrate—CYP2A6—prostate cancer	0.000273	0.0708	CrCbGaD
Fenofibrate—CYP3A4—renal system—prostate cancer	0.000252	0.0314	CbGeAlD
Fenofibrate—CYP2C8—testis—prostate cancer	0.00024	0.03	CbGeAlD
Fenofibrate—Indomethacin—CXCL8—prostate cancer	0.000222	0.0575	CrCbGaD
Fenofibrate—Clofibrate—CYP2E1—prostate cancer	0.000194	0.0503	CrCbGaD
Fenofibrate—Clofibrate—CYP1A1—prostate cancer	0.000191	0.0496	CrCbGaD
Fenofibrate—Bezafibrate—CYP1A1—prostate cancer	0.00014	0.0362	CrCbGaD
Fenofibrate—Clofibrate—CYP3A4—prostate cancer	0.000122	0.0317	CrCbGaD
Fenofibrate—Indomethacin—CYP2C19—prostate cancer	0.000104	0.0269	CrCbGaD
Fenofibrate—Bezafibrate—CYP3A4—prostate cancer	8.91e-05	0.0231	CrCbGaD
Fenofibrate—Indomethacin—PTGS2—prostate cancer	6.47e-05	0.0168	CrCbGaD
Fenofibrate—Hepatitis—Epirubicin—prostate cancer	2.69e-05	0.00017	CcSEcCtD
Fenofibrate—Thrombocytopenia—Capecitabine—prostate cancer	2.68e-05	0.00017	CcSEcCtD
Fenofibrate—Tachycardia—Capecitabine—prostate cancer	2.67e-05	0.000169	CcSEcCtD
Fenofibrate—Pharyngitis—Epirubicin—prostate cancer	2.67e-05	0.000169	CcSEcCtD
Fenofibrate—Skin disorder—Capecitabine—prostate cancer	2.66e-05	0.000168	CcSEcCtD
Fenofibrate—Sweating—Doxorubicin—prostate cancer	2.66e-05	0.000168	CcSEcCtD
Fenofibrate—Hyperhidrosis—Capecitabine—prostate cancer	2.65e-05	0.000168	CcSEcCtD
Fenofibrate—Oedema peripheral—Epirubicin—prostate cancer	2.65e-05	0.000167	CcSEcCtD
Fenofibrate—Hypotension—Docetaxel—prostate cancer	2.64e-05	0.000167	CcSEcCtD
Fenofibrate—Connective tissue disorder—Epirubicin—prostate cancer	2.64e-05	0.000167	CcSEcCtD
Fenofibrate—Hepatobiliary disease—Doxorubicin—prostate cancer	2.62e-05	0.000166	CcSEcCtD
Fenofibrate—Anorexia—Capecitabine—prostate cancer	2.61e-05	0.000165	CcSEcCtD
Fenofibrate—Nausea—Estradiol—prostate cancer	2.61e-05	0.000165	CcSEcCtD
Fenofibrate—Vomiting—Mitoxantrone—prostate cancer	2.6e-05	0.000165	CcSEcCtD
Fenofibrate—Sinusitis—Doxorubicin—prostate cancer	2.6e-05	0.000164	CcSEcCtD
Fenofibrate—Visual impairment—Epirubicin—prostate cancer	2.59e-05	0.000164	CcSEcCtD
Fenofibrate—Hypertension—Prednisone—prostate cancer	2.58e-05	0.000163	CcSEcCtD
Fenofibrate—Rash—Mitoxantrone—prostate cancer	2.58e-05	0.000163	CcSEcCtD
Fenofibrate—Dermatitis—Mitoxantrone—prostate cancer	2.58e-05	0.000163	CcSEcCtD
Fenofibrate—Musculoskeletal discomfort—Docetaxel—prostate cancer	2.58e-05	0.000163	CcSEcCtD
Fenofibrate—Headache—Mitoxantrone—prostate cancer	2.56e-05	0.000162	CcSEcCtD
Fenofibrate—Hypotension—Capecitabine—prostate cancer	2.56e-05	0.000162	CcSEcCtD
Fenofibrate—Insomnia—Docetaxel—prostate cancer	2.56e-05	0.000162	CcSEcCtD
Fenofibrate—Arthralgia—Prednisone—prostate cancer	2.55e-05	0.000161	CcSEcCtD
Fenofibrate—Myalgia—Prednisone—prostate cancer	2.55e-05	0.000161	CcSEcCtD
Fenofibrate—Paraesthesia—Docetaxel—prostate cancer	2.54e-05	0.000161	CcSEcCtD
Fenofibrate—Anxiety—Prednisone—prostate cancer	2.54e-05	0.000161	CcSEcCtD
Fenofibrate—Unspecified disorder of skin and subcutaneous tissue—Prednisone—prostate cancer	2.53e-05	0.00016	CcSEcCtD
Fenofibrate—Dyspnoea—Docetaxel—prostate cancer	2.52e-05	0.00016	CcSEcCtD
Fenofibrate—Somnolence—Docetaxel—prostate cancer	2.52e-05	0.000159	CcSEcCtD
Fenofibrate—Discomfort—Prednisone—prostate cancer	2.52e-05	0.000159	CcSEcCtD
Fenofibrate—Eye disorder—Epirubicin—prostate cancer	2.51e-05	0.000159	CcSEcCtD
Fenofibrate—Hypersensitivity—Etoposide—prostate cancer	2.51e-05	0.000159	CcSEcCtD
Fenofibrate—Musculoskeletal discomfort—Capecitabine—prostate cancer	2.5e-05	0.000158	CcSEcCtD
Fenofibrate—Cardiac disorder—Epirubicin—prostate cancer	2.49e-05	0.000158	CcSEcCtD
Fenofibrate—Rhinitis—Doxorubicin—prostate cancer	2.49e-05	0.000158	CcSEcCtD
Fenofibrate—Dyspepsia—Docetaxel—prostate cancer	2.49e-05	0.000158	CcSEcCtD
Fenofibrate—Hepatitis—Doxorubicin—prostate cancer	2.49e-05	0.000157	CcSEcCtD
Fenofibrate—Insomnia—Capecitabine—prostate cancer	2.48e-05	0.000157	CcSEcCtD
Fenofibrate—Pharyngitis—Doxorubicin—prostate cancer	2.47e-05	0.000156	CcSEcCtD
Fenofibrate—Paraesthesia—Capecitabine—prostate cancer	2.46e-05	0.000156	CcSEcCtD
Fenofibrate—Decreased appetite—Docetaxel—prostate cancer	2.46e-05	0.000156	CcSEcCtD
Fenofibrate—Oedema peripheral—Doxorubicin—prostate cancer	2.45e-05	0.000155	CcSEcCtD
Fenofibrate—Gastrointestinal disorder—Docetaxel—prostate cancer	2.44e-05	0.000155	CcSEcCtD
Fenofibrate—Asthenia—Etoposide—prostate cancer	2.44e-05	0.000155	CcSEcCtD
Fenofibrate—Connective tissue disorder—Doxorubicin—prostate cancer	2.44e-05	0.000155	CcSEcCtD
Fenofibrate—Dyspnoea—Capecitabine—prostate cancer	2.44e-05	0.000155	CcSEcCtD
Fenofibrate—Oedema—Prednisone—prostate cancer	2.44e-05	0.000154	CcSEcCtD
Fenofibrate—Fatigue—Docetaxel—prostate cancer	2.44e-05	0.000154	CcSEcCtD
Fenofibrate—Angiopathy—Epirubicin—prostate cancer	2.44e-05	0.000154	CcSEcCtD
Fenofibrate—Nausea—Mitoxantrone—prostate cancer	2.43e-05	0.000154	CcSEcCtD
Fenofibrate—Infection—Prednisone—prostate cancer	2.42e-05	0.000153	CcSEcCtD
Fenofibrate—Mediastinal disorder—Epirubicin—prostate cancer	2.42e-05	0.000153	CcSEcCtD
Fenofibrate—Pain—Docetaxel—prostate cancer	2.42e-05	0.000153	CcSEcCtD
Fenofibrate—Constipation—Docetaxel—prostate cancer	2.42e-05	0.000153	CcSEcCtD
Fenofibrate—Dyspepsia—Capecitabine—prostate cancer	2.41e-05	0.000153	CcSEcCtD
Fenofibrate—Pruritus—Etoposide—prostate cancer	2.41e-05	0.000152	CcSEcCtD
Fenofibrate—Arrhythmia—Epirubicin—prostate cancer	2.4e-05	0.000152	CcSEcCtD
Fenofibrate—Visual impairment—Doxorubicin—prostate cancer	2.4e-05	0.000152	CcSEcCtD
Fenofibrate—Nervous system disorder—Prednisone—prostate cancer	2.39e-05	0.000151	CcSEcCtD
Fenofibrate—Tachycardia—Prednisone—prostate cancer	2.38e-05	0.000151	CcSEcCtD
Fenofibrate—Decreased appetite—Capecitabine—prostate cancer	2.38e-05	0.000151	CcSEcCtD
Fenofibrate—Alopecia—Epirubicin—prostate cancer	2.37e-05	0.00015	CcSEcCtD
Fenofibrate—Skin disorder—Prednisone—prostate cancer	2.37e-05	0.00015	CcSEcCtD
Fenofibrate—Gastrointestinal disorder—Capecitabine—prostate cancer	2.37e-05	0.00015	CcSEcCtD
Fenofibrate—Fatigue—Capecitabine—prostate cancer	2.36e-05	0.000149	CcSEcCtD
Fenofibrate—Hyperhidrosis—Prednisone—prostate cancer	2.36e-05	0.000149	CcSEcCtD
Fenofibrate—Mental disorder—Epirubicin—prostate cancer	2.35e-05	0.000149	CcSEcCtD
Fenofibrate—Pain—Capecitabine—prostate cancer	2.34e-05	0.000148	CcSEcCtD
Fenofibrate—Constipation—Capecitabine—prostate cancer	2.34e-05	0.000148	CcSEcCtD
Fenofibrate—Malnutrition—Epirubicin—prostate cancer	2.34e-05	0.000148	CcSEcCtD
Fenofibrate—Erythema—Epirubicin—prostate cancer	2.34e-05	0.000148	CcSEcCtD
Fenofibrate—Feeling abnormal—Docetaxel—prostate cancer	2.33e-05	0.000148	CcSEcCtD
Fenofibrate—Diarrhoea—Etoposide—prostate cancer	2.33e-05	0.000147	CcSEcCtD
Fenofibrate—Anorexia—Prednisone—prostate cancer	2.33e-05	0.000147	CcSEcCtD
Fenofibrate—Eye disorder—Doxorubicin—prostate cancer	2.32e-05	0.000147	CcSEcCtD
Fenofibrate—Gastrointestinal pain—Docetaxel—prostate cancer	2.31e-05	0.000146	CcSEcCtD
Fenofibrate—Cardiac disorder—Doxorubicin—prostate cancer	2.31e-05	0.000146	CcSEcCtD
Fenofibrate—Flatulence—Epirubicin—prostate cancer	2.3e-05	0.000146	CcSEcCtD
Fenofibrate—Tension—Epirubicin—prostate cancer	2.3e-05	0.000145	CcSEcCtD
Fenofibrate—Nervousness—Epirubicin—prostate cancer	2.27e-05	0.000144	CcSEcCtD
Fenofibrate—Back pain—Epirubicin—prostate cancer	2.26e-05	0.000143	CcSEcCtD
Fenofibrate—Feeling abnormal—Capecitabine—prostate cancer	2.26e-05	0.000143	CcSEcCtD
Fenofibrate—Angiopathy—Doxorubicin—prostate cancer	2.26e-05	0.000143	CcSEcCtD
Fenofibrate—Dizziness—Etoposide—prostate cancer	2.25e-05	0.000142	CcSEcCtD
Fenofibrate—Muscle spasms—Epirubicin—prostate cancer	2.25e-05	0.000142	CcSEcCtD
Fenofibrate—Gastrointestinal pain—Capecitabine—prostate cancer	2.24e-05	0.000142	CcSEcCtD
Fenofibrate—Mediastinal disorder—Doxorubicin—prostate cancer	2.24e-05	0.000142	CcSEcCtD
Fenofibrate—Body temperature increased—Docetaxel—prostate cancer	2.24e-05	0.000142	CcSEcCtD
Fenofibrate—Abdominal pain—Docetaxel—prostate cancer	2.24e-05	0.000142	CcSEcCtD
Fenofibrate—Musculoskeletal discomfort—Prednisone—prostate cancer	2.22e-05	0.000141	CcSEcCtD
Fenofibrate—Arrhythmia—Doxorubicin—prostate cancer	2.22e-05	0.00014	CcSEcCtD
Fenofibrate—Insomnia—Prednisone—prostate cancer	2.21e-05	0.00014	CcSEcCtD
Fenofibrate—Alopecia—Doxorubicin—prostate cancer	2.2e-05	0.000139	CcSEcCtD
Fenofibrate—Paraesthesia—Prednisone—prostate cancer	2.19e-05	0.000139	CcSEcCtD
Fenofibrate—Mental disorder—Doxorubicin—prostate cancer	2.18e-05	0.000138	CcSEcCtD
Fenofibrate—Urticaria—Capecitabine—prostate cancer	2.18e-05	0.000138	CcSEcCtD
Fenofibrate—Ill-defined disorder—Epirubicin—prostate cancer	2.17e-05	0.000137	CcSEcCtD
Fenofibrate—Abdominal pain—Capecitabine—prostate cancer	2.17e-05	0.000137	CcSEcCtD
Fenofibrate—Body temperature increased—Capecitabine—prostate cancer	2.17e-05	0.000137	CcSEcCtD
Fenofibrate—Vomiting—Etoposide—prostate cancer	2.17e-05	0.000137	CcSEcCtD
Fenofibrate—Malnutrition—Doxorubicin—prostate cancer	2.16e-05	0.000137	CcSEcCtD
Fenofibrate—Erythema—Doxorubicin—prostate cancer	2.16e-05	0.000137	CcSEcCtD
Fenofibrate—Anaemia—Epirubicin—prostate cancer	2.16e-05	0.000137	CcSEcCtD
Fenofibrate—Dyspepsia—Prednisone—prostate cancer	2.15e-05	0.000136	CcSEcCtD
Fenofibrate—Rash—Etoposide—prostate cancer	2.15e-05	0.000136	CcSEcCtD
Fenofibrate—Dermatitis—Etoposide—prostate cancer	2.15e-05	0.000136	CcSEcCtD
Fenofibrate—Headache—Etoposide—prostate cancer	2.13e-05	0.000135	CcSEcCtD
Fenofibrate—Flatulence—Doxorubicin—prostate cancer	2.13e-05	0.000135	CcSEcCtD
Fenofibrate—Tension—Doxorubicin—prostate cancer	2.12e-05	0.000134	CcSEcCtD
Fenofibrate—Decreased appetite—Prednisone—prostate cancer	2.12e-05	0.000134	CcSEcCtD
Fenofibrate—Malaise—Epirubicin—prostate cancer	2.11e-05	0.000133	CcSEcCtD
Fenofibrate—Fatigue—Prednisone—prostate cancer	2.1e-05	0.000133	CcSEcCtD
Fenofibrate—Nervousness—Doxorubicin—prostate cancer	2.1e-05	0.000133	CcSEcCtD
Fenofibrate—Vertigo—Epirubicin—prostate cancer	2.1e-05	0.000133	CcSEcCtD
Fenofibrate—Leukopenia—Epirubicin—prostate cancer	2.09e-05	0.000132	CcSEcCtD
Fenofibrate—Back pain—Doxorubicin—prostate cancer	2.09e-05	0.000132	CcSEcCtD
Fenofibrate—Constipation—Prednisone—prostate cancer	2.09e-05	0.000132	CcSEcCtD
Fenofibrate—Hypersensitivity—Docetaxel—prostate cancer	2.09e-05	0.000132	CcSEcCtD
Fenofibrate—Muscle spasms—Doxorubicin—prostate cancer	2.08e-05	0.000132	CcSEcCtD
Fenofibrate—Palpitations—Epirubicin—prostate cancer	2.07e-05	0.000131	CcSEcCtD
Fenofibrate—Cough—Epirubicin—prostate cancer	2.04e-05	0.000129	CcSEcCtD
Fenofibrate—Asthenia—Docetaxel—prostate cancer	2.03e-05	0.000128	CcSEcCtD
Fenofibrate—Nausea—Etoposide—prostate cancer	2.02e-05	0.000128	CcSEcCtD
Fenofibrate—Hypertension—Epirubicin—prostate cancer	2.02e-05	0.000128	CcSEcCtD
Fenofibrate—Hypersensitivity—Capecitabine—prostate cancer	2.02e-05	0.000128	CcSEcCtD
Fenofibrate—Feeling abnormal—Prednisone—prostate cancer	2.01e-05	0.000127	CcSEcCtD
Fenofibrate—Ill-defined disorder—Doxorubicin—prostate cancer	2.01e-05	0.000127	CcSEcCtD
Fenofibrate—Pruritus—Docetaxel—prostate cancer	2e-05	0.000127	CcSEcCtD
Fenofibrate—Anaemia—Doxorubicin—prostate cancer	2e-05	0.000127	CcSEcCtD
Fenofibrate—Gastrointestinal pain—Prednisone—prostate cancer	2e-05	0.000126	CcSEcCtD
Fenofibrate—Arthralgia—Epirubicin—prostate cancer	1.99e-05	0.000126	CcSEcCtD
Fenofibrate—Chest pain—Epirubicin—prostate cancer	1.99e-05	0.000126	CcSEcCtD
Fenofibrate—Myalgia—Epirubicin—prostate cancer	1.99e-05	0.000126	CcSEcCtD
Fenofibrate—Anxiety—Epirubicin—prostate cancer	1.98e-05	0.000126	CcSEcCtD
Fenofibrate—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—prostate cancer	1.98e-05	0.000125	CcSEcCtD
Fenofibrate—Discomfort—Epirubicin—prostate cancer	1.97e-05	0.000124	CcSEcCtD
Fenofibrate—Asthenia—Capecitabine—prostate cancer	1.97e-05	0.000124	CcSEcCtD
Fenofibrate—Malaise—Doxorubicin—prostate cancer	1.95e-05	0.000123	CcSEcCtD
Fenofibrate—Dry mouth—Epirubicin—prostate cancer	1.95e-05	0.000123	CcSEcCtD
Fenofibrate—Vertigo—Doxorubicin—prostate cancer	1.94e-05	0.000123	CcSEcCtD
Fenofibrate—Urticaria—Prednisone—prostate cancer	1.94e-05	0.000123	CcSEcCtD
Fenofibrate—Pruritus—Capecitabine—prostate cancer	1.94e-05	0.000123	CcSEcCtD
Fenofibrate—Leukopenia—Doxorubicin—prostate cancer	1.94e-05	0.000123	CcSEcCtD
Fenofibrate—Diarrhoea—Docetaxel—prostate cancer	1.94e-05	0.000122	CcSEcCtD
Fenofibrate—Body temperature increased—Prednisone—prostate cancer	1.93e-05	0.000122	CcSEcCtD
Fenofibrate—Abdominal pain—Prednisone—prostate cancer	1.93e-05	0.000122	CcSEcCtD
Fenofibrate—Palpitations—Doxorubicin—prostate cancer	1.91e-05	0.000121	CcSEcCtD
Fenofibrate—Oedema—Epirubicin—prostate cancer	1.91e-05	0.000121	CcSEcCtD
Fenofibrate—Infection—Epirubicin—prostate cancer	1.9e-05	0.00012	CcSEcCtD
Fenofibrate—Cough—Doxorubicin—prostate cancer	1.89e-05	0.000119	CcSEcCtD
Fenofibrate—Diarrhoea—Capecitabine—prostate cancer	1.87e-05	0.000119	CcSEcCtD
Fenofibrate—Nervous system disorder—Epirubicin—prostate cancer	1.87e-05	0.000118	CcSEcCtD
Fenofibrate—Dizziness—Docetaxel—prostate cancer	1.87e-05	0.000118	CcSEcCtD
Fenofibrate—Thrombocytopenia—Epirubicin—prostate cancer	1.87e-05	0.000118	CcSEcCtD
Fenofibrate—Hypertension—Doxorubicin—prostate cancer	1.87e-05	0.000118	CcSEcCtD
Fenofibrate—Tachycardia—Epirubicin—prostate cancer	1.86e-05	0.000118	CcSEcCtD
Fenofibrate—Skin disorder—Epirubicin—prostate cancer	1.85e-05	0.000117	CcSEcCtD
Fenofibrate—Hyperhidrosis—Epirubicin—prostate cancer	1.85e-05	0.000117	CcSEcCtD
Fenofibrate—Myalgia—Doxorubicin—prostate cancer	1.84e-05	0.000117	CcSEcCtD
Fenofibrate—Chest pain—Doxorubicin—prostate cancer	1.84e-05	0.000117	CcSEcCtD
Fenofibrate—Arthralgia—Doxorubicin—prostate cancer	1.84e-05	0.000117	CcSEcCtD
Fenofibrate—Anxiety—Doxorubicin—prostate cancer	1.84e-05	0.000116	CcSEcCtD
Fenofibrate—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—prostate cancer	1.83e-05	0.000116	CcSEcCtD
Fenofibrate—Discomfort—Doxorubicin—prostate cancer	1.82e-05	0.000115	CcSEcCtD
Fenofibrate—Anorexia—Epirubicin—prostate cancer	1.82e-05	0.000115	CcSEcCtD
Fenofibrate—Dizziness—Capecitabine—prostate cancer	1.81e-05	0.000115	CcSEcCtD
Fenofibrate—Dry mouth—Doxorubicin—prostate cancer	1.8e-05	0.000114	CcSEcCtD
Fenofibrate—Vomiting—Docetaxel—prostate cancer	1.8e-05	0.000114	CcSEcCtD
Fenofibrate—Hypersensitivity—Prednisone—prostate cancer	1.8e-05	0.000114	CcSEcCtD
Fenofibrate—Rash—Docetaxel—prostate cancer	1.78e-05	0.000113	CcSEcCtD
Fenofibrate—Hypotension—Epirubicin—prostate cancer	1.78e-05	0.000113	CcSEcCtD
Fenofibrate—Dermatitis—Docetaxel—prostate cancer	1.78e-05	0.000113	CcSEcCtD
Fenofibrate—Headache—Docetaxel—prostate cancer	1.77e-05	0.000112	CcSEcCtD
Fenofibrate—Oedema—Doxorubicin—prostate cancer	1.77e-05	0.000112	CcSEcCtD
Fenofibrate—Infection—Doxorubicin—prostate cancer	1.75e-05	0.000111	CcSEcCtD
Fenofibrate—Asthenia—Prednisone—prostate cancer	1.75e-05	0.000111	CcSEcCtD
Fenofibrate—Vomiting—Capecitabine—prostate cancer	1.74e-05	0.00011	CcSEcCtD
Fenofibrate—Musculoskeletal discomfort—Epirubicin—prostate cancer	1.74e-05	0.00011	CcSEcCtD
Fenofibrate—Nervous system disorder—Doxorubicin—prostate cancer	1.73e-05	0.00011	CcSEcCtD
Fenofibrate—Thrombocytopenia—Doxorubicin—prostate cancer	1.73e-05	0.000109	CcSEcCtD
Fenofibrate—Rash—Capecitabine—prostate cancer	1.73e-05	0.000109	CcSEcCtD
Fenofibrate—Pruritus—Prednisone—prostate cancer	1.73e-05	0.000109	CcSEcCtD
Fenofibrate—Insomnia—Epirubicin—prostate cancer	1.73e-05	0.000109	CcSEcCtD
Fenofibrate—Dermatitis—Capecitabine—prostate cancer	1.73e-05	0.000109	CcSEcCtD
Fenofibrate—Tachycardia—Doxorubicin—prostate cancer	1.72e-05	0.000109	CcSEcCtD
Fenofibrate—Headache—Capecitabine—prostate cancer	1.72e-05	0.000109	CcSEcCtD
Fenofibrate—Skin disorder—Doxorubicin—prostate cancer	1.72e-05	0.000109	CcSEcCtD
Fenofibrate—Paraesthesia—Epirubicin—prostate cancer	1.71e-05	0.000108	CcSEcCtD
Fenofibrate—Hyperhidrosis—Doxorubicin—prostate cancer	1.71e-05	0.000108	CcSEcCtD
Fenofibrate—Dyspnoea—Epirubicin—prostate cancer	1.7e-05	0.000108	CcSEcCtD
Fenofibrate—Somnolence—Epirubicin—prostate cancer	1.7e-05	0.000107	CcSEcCtD
Fenofibrate—Anorexia—Doxorubicin—prostate cancer	1.68e-05	0.000107	CcSEcCtD
Fenofibrate—Nausea—Docetaxel—prostate cancer	1.68e-05	0.000106	CcSEcCtD
Fenofibrate—Dyspepsia—Epirubicin—prostate cancer	1.68e-05	0.000106	CcSEcCtD
Fenofibrate—Diarrhoea—Prednisone—prostate cancer	1.67e-05	0.000106	CcSEcCtD
Fenofibrate—Decreased appetite—Epirubicin—prostate cancer	1.66e-05	0.000105	CcSEcCtD
Fenofibrate—Hypotension—Doxorubicin—prostate cancer	1.65e-05	0.000104	CcSEcCtD
Fenofibrate—Gastrointestinal disorder—Epirubicin—prostate cancer	1.65e-05	0.000104	CcSEcCtD
Fenofibrate—Fatigue—Epirubicin—prostate cancer	1.65e-05	0.000104	CcSEcCtD
Fenofibrate—Pain—Epirubicin—prostate cancer	1.63e-05	0.000103	CcSEcCtD
Fenofibrate—Constipation—Epirubicin—prostate cancer	1.63e-05	0.000103	CcSEcCtD
Fenofibrate—Nausea—Capecitabine—prostate cancer	1.63e-05	0.000103	CcSEcCtD
Fenofibrate—Dizziness—Prednisone—prostate cancer	1.61e-05	0.000102	CcSEcCtD
Fenofibrate—Musculoskeletal discomfort—Doxorubicin—prostate cancer	1.61e-05	0.000102	CcSEcCtD
Fenofibrate—Insomnia—Doxorubicin—prostate cancer	1.6e-05	0.000101	CcSEcCtD
Fenofibrate—Paraesthesia—Doxorubicin—prostate cancer	1.59e-05	0.0001	CcSEcCtD
Fenofibrate—Dyspnoea—Doxorubicin—prostate cancer	1.57e-05	9.96e-05	CcSEcCtD
Fenofibrate—Feeling abnormal—Epirubicin—prostate cancer	1.57e-05	9.95e-05	CcSEcCtD
Fenofibrate—Somnolence—Doxorubicin—prostate cancer	1.57e-05	9.93e-05	CcSEcCtD
Fenofibrate—Gastrointestinal pain—Epirubicin—prostate cancer	1.56e-05	9.87e-05	CcSEcCtD
Fenofibrate—Dyspepsia—Doxorubicin—prostate cancer	1.55e-05	9.84e-05	CcSEcCtD
Fenofibrate—Vomiting—Prednisone—prostate cancer	1.55e-05	9.82e-05	CcSEcCtD
Fenofibrate—Rash—Prednisone—prostate cancer	1.54e-05	9.74e-05	CcSEcCtD
Fenofibrate—Dermatitis—Prednisone—prostate cancer	1.54e-05	9.73e-05	CcSEcCtD
Fenofibrate—Decreased appetite—Doxorubicin—prostate cancer	1.54e-05	9.71e-05	CcSEcCtD
Fenofibrate—Headache—Prednisone—prostate cancer	1.53e-05	9.67e-05	CcSEcCtD
Fenofibrate—Gastrointestinal disorder—Doxorubicin—prostate cancer	1.52e-05	9.65e-05	CcSEcCtD
Fenofibrate—Fatigue—Doxorubicin—prostate cancer	1.52e-05	9.63e-05	CcSEcCtD
Fenofibrate—Urticaria—Epirubicin—prostate cancer	1.52e-05	9.59e-05	CcSEcCtD
Fenofibrate—Pain—Doxorubicin—prostate cancer	1.51e-05	9.56e-05	CcSEcCtD
Fenofibrate—Constipation—Doxorubicin—prostate cancer	1.51e-05	9.56e-05	CcSEcCtD
Fenofibrate—Abdominal pain—Epirubicin—prostate cancer	1.51e-05	9.55e-05	CcSEcCtD
Fenofibrate—Body temperature increased—Epirubicin—prostate cancer	1.51e-05	9.55e-05	CcSEcCtD
Fenofibrate—Feeling abnormal—Doxorubicin—prostate cancer	1.46e-05	9.21e-05	CcSEcCtD
Fenofibrate—Nausea—Prednisone—prostate cancer	1.45e-05	9.17e-05	CcSEcCtD
Fenofibrate—Gastrointestinal pain—Doxorubicin—prostate cancer	1.44e-05	9.14e-05	CcSEcCtD
Fenofibrate—Hypersensitivity—Epirubicin—prostate cancer	1.41e-05	8.9e-05	CcSEcCtD
Fenofibrate—Urticaria—Doxorubicin—prostate cancer	1.4e-05	8.88e-05	CcSEcCtD
Fenofibrate—Abdominal pain—Doxorubicin—prostate cancer	1.4e-05	8.83e-05	CcSEcCtD
Fenofibrate—Body temperature increased—Doxorubicin—prostate cancer	1.4e-05	8.83e-05	CcSEcCtD
Fenofibrate—Asthenia—Epirubicin—prostate cancer	1.37e-05	8.66e-05	CcSEcCtD
Fenofibrate—Pruritus—Epirubicin—prostate cancer	1.35e-05	8.54e-05	CcSEcCtD
Fenofibrate—Diarrhoea—Epirubicin—prostate cancer	1.31e-05	8.26e-05	CcSEcCtD
Fenofibrate—Hypersensitivity—Doxorubicin—prostate cancer	1.3e-05	8.23e-05	CcSEcCtD
Fenofibrate—Asthenia—Doxorubicin—prostate cancer	1.27e-05	8.02e-05	CcSEcCtD
Fenofibrate—Dizziness—Epirubicin—prostate cancer	1.26e-05	7.99e-05	CcSEcCtD
Fenofibrate—Pruritus—Doxorubicin—prostate cancer	1.25e-05	7.91e-05	CcSEcCtD
Fenofibrate—Vomiting—Epirubicin—prostate cancer	1.21e-05	7.68e-05	CcSEcCtD
Fenofibrate—Diarrhoea—Doxorubicin—prostate cancer	1.21e-05	7.65e-05	CcSEcCtD
Fenofibrate—Rash—Epirubicin—prostate cancer	1.2e-05	7.61e-05	CcSEcCtD
Fenofibrate—Dermatitis—Epirubicin—prostate cancer	1.2e-05	7.61e-05	CcSEcCtD
Fenofibrate—Headache—Epirubicin—prostate cancer	1.2e-05	7.57e-05	CcSEcCtD
Fenofibrate—Dizziness—Doxorubicin—prostate cancer	1.17e-05	7.39e-05	CcSEcCtD
Fenofibrate—Nausea—Epirubicin—prostate cancer	1.13e-05	7.17e-05	CcSEcCtD
Fenofibrate—Vomiting—Doxorubicin—prostate cancer	1.12e-05	7.1e-05	CcSEcCtD
Fenofibrate—Rash—Doxorubicin—prostate cancer	1.11e-05	7.05e-05	CcSEcCtD
Fenofibrate—Dermatitis—Doxorubicin—prostate cancer	1.11e-05	7.04e-05	CcSEcCtD
Fenofibrate—Headache—Doxorubicin—prostate cancer	1.11e-05	7e-05	CcSEcCtD
Fenofibrate—Nausea—Doxorubicin—prostate cancer	1.05e-05	6.64e-05	CcSEcCtD
Fenofibrate—CYP2C8—Metabolism—SULT1A1—prostate cancer	7.18e-06	8.76e-05	CbGpPWpGaD
Fenofibrate—CYP2C8—Metabolism—ABCG5—prostate cancer	7.18e-06	8.76e-05	CbGpPWpGaD
Fenofibrate—CYP3A4—Metabolism—PGAM2—prostate cancer	7.17e-06	8.74e-05	CbGpPWpGaD
Fenofibrate—CYP3A4—Metabolism—RFK—prostate cancer	7.17e-06	8.74e-05	CbGpPWpGaD
Fenofibrate—CYP3A4—Metabolism—MBTPS1—prostate cancer	7.17e-06	8.74e-05	CbGpPWpGaD
Fenofibrate—CYP3A4—Metabolism—NAGLU—prostate cancer	7.17e-06	8.74e-05	CbGpPWpGaD
Fenofibrate—CYP3A4—Metabolism—AOX1—prostate cancer	7.17e-06	8.74e-05	CbGpPWpGaD
Fenofibrate—CYP3A4—Metabolism—SULT2B1—prostate cancer	7.17e-06	8.74e-05	CbGpPWpGaD
Fenofibrate—CYP3A4—Metabolism—GSTM3—prostate cancer	7.17e-06	8.74e-05	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism—UMPS—prostate cancer	7.14e-06	8.71e-05	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism—PHGDH—prostate cancer	7.14e-06	8.71e-05	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism—ARG2—prostate cancer	7.14e-06	8.71e-05	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism of lipids and lipoproteins—RXRA—prostate cancer	7.11e-06	8.67e-05	CbGpPWpGaD
Fenofibrate—CYP2C8—Metabolism—GSTA1—prostate cancer	7.02e-06	8.56e-05	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism—LDHB—prostate cancer	7e-06	8.54e-05	CbGpPWpGaD
Fenofibrate—CYP2C8—Metabolism—NAT2—prostate cancer	6.94e-06	8.46e-05	CbGpPWpGaD
Fenofibrate—CYP2C8—Metabolism—GSTO1—prostate cancer	6.94e-06	8.46e-05	CbGpPWpGaD
Fenofibrate—CYP2C8—Metabolism—HSD3B2—prostate cancer	6.94e-06	8.46e-05	CbGpPWpGaD
Fenofibrate—PPARA—Metabolism—PIK3CD—prostate cancer	6.9e-06	8.41e-05	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism—CYP3A5—prostate cancer	6.88e-06	8.38e-05	CbGpPWpGaD
Fenofibrate—CYP3A4—Metabolism—AMACR—prostate cancer	6.8e-06	8.29e-05	CbGpPWpGaD
Fenofibrate—CYP3A4—Metabolism—CYP3A43—prostate cancer	6.8e-06	8.29e-05	CbGpPWpGaD
Fenofibrate—CYP3A4—Metabolism—SRD5A2—prostate cancer	6.8e-06	8.29e-05	CbGpPWpGaD
Fenofibrate—CYP3A4—Metabolism—NAT1—prostate cancer	6.8e-06	8.29e-05	CbGpPWpGaD
Fenofibrate—CYP3A4—Metabolism—DEGS1—prostate cancer	6.8e-06	8.29e-05	CbGpPWpGaD
Fenofibrate—CYP2C8—Metabolism of lipids and lipoproteins—PPARA—prostate cancer	6.67e-06	8.13e-05	CbGpPWpGaD
Fenofibrate—CYP2C8—Metabolism—CYP2C18—prostate cancer	6.65e-06	8.11e-05	CbGpPWpGaD
Fenofibrate—CYP2C8—Metabolism—PLCB2—prostate cancer	6.65e-06	8.11e-05	CbGpPWpGaD
Fenofibrate—CYP2C8—Metabolism—LRP2—prostate cancer	6.65e-06	8.11e-05	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism—PDHA1—prostate cancer	6.64e-06	8.1e-05	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism—TCN2—prostate cancer	6.64e-06	8.1e-05	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism—UCP3—prostate cancer	6.64e-06	8.1e-05	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism—GSTA3—prostate cancer	6.64e-06	8.1e-05	CbGpPWpGaD
Fenofibrate—CYP2C8—Metabolism—P4HB—prostate cancer	6.52e-06	7.95e-05	CbGpPWpGaD
Fenofibrate—PPARA—Metabolism—NOS3—prostate cancer	6.51e-06	7.94e-05	CbGpPWpGaD
Fenofibrate—CYP3A4—Metabolism—HSD17B1—prostate cancer	6.48e-06	7.91e-05	CbGpPWpGaD
Fenofibrate—CYP2C8—Metabolism—SLC22A1—prostate cancer	6.34e-06	7.74e-05	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism—HSD3B1—prostate cancer	6.33e-06	7.72e-05	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism—SLC22A3—prostate cancer	6.33e-06	7.72e-05	CbGpPWpGaD
Fenofibrate—CYP2C8—Metabolism of lipids and lipoproteins—CAV1—prostate cancer	6.27e-06	7.65e-05	CbGpPWpGaD
Fenofibrate—CYP2C8—Metabolism—SULT2A1—prostate cancer	6.18e-06	7.54e-05	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism of lipids and lipoproteins—LPL—prostate cancer	6.15e-06	7.5e-05	CbGpPWpGaD
Fenofibrate—CYP2C8—Metabolism—MED12—prostate cancer	6.08e-06	7.42e-05	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism—GSTA4—prostate cancer	6.07e-06	7.41e-05	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism—TBXAS1—prostate cancer	6.07e-06	7.41e-05	CbGpPWpGaD
Fenofibrate—CYP2C8—Metabolism—GNG5—prostate cancer	6.03e-06	7.36e-05	CbGpPWpGaD
Fenofibrate—PPARA—Metabolism—PIK3CB—prostate cancer	6.01e-06	7.33e-05	CbGpPWpGaD
Fenofibrate—PPARA—Metabolism—PTGS2—prostate cancer	5.96e-06	7.26e-05	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—prostate cancer	5.94e-06	7.24e-05	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism—GSTA2—prostate cancer	5.92e-06	7.22e-05	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism—SULT1A1—prostate cancer	5.85e-06	7.13e-05	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism—ABCG5—prostate cancer	5.85e-06	7.13e-05	CbGpPWpGaD
Fenofibrate—CYP2C8—Metabolism—NCOA3—prostate cancer	5.81e-06	7.09e-05	CbGpPWpGaD
Fenofibrate—CYP3A4—Metabolism—B4GALT4—prostate cancer	5.78e-06	7.05e-05	CbGpPWpGaD
Fenofibrate—CYP3A4—Metabolism—HPGD—prostate cancer	5.78e-06	7.05e-05	CbGpPWpGaD
Fenofibrate—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—prostate cancer	5.71e-06	6.97e-05	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism—GSTA1—prostate cancer	5.71e-06	6.96e-05	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism—GSTO1—prostate cancer	5.65e-06	6.89e-05	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism—NAT2—prostate cancer	5.65e-06	6.89e-05	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism—HSD3B2—prostate cancer	5.65e-06	6.89e-05	CbGpPWpGaD
Fenofibrate—PPARA—Gene Expression—MYC—prostate cancer	5.55e-06	6.77e-05	CbGpPWpGaD
Fenofibrate—CYP2C8—Metabolism—HPGDS—prostate cancer	5.55e-06	6.76e-05	CbGpPWpGaD
Fenofibrate—CYP2C8—Metabolism—CYP2C19—prostate cancer	5.51e-06	6.72e-05	CbGpPWpGaD
Fenofibrate—CYP3A4—Metabolism—TNFRSF21—prostate cancer	5.43e-06	6.63e-05	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism of lipids and lipoproteins—PPARA—prostate cancer	5.43e-06	6.62e-05	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism—CYP2C18—prostate cancer	5.41e-06	6.6e-05	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism—LRP2—prostate cancer	5.41e-06	6.6e-05	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism—PLCB2—prostate cancer	5.41e-06	6.6e-05	CbGpPWpGaD
Fenofibrate—CYP2C8—Metabolism—GSTT1—prostate cancer	5.38e-06	6.56e-05	CbGpPWpGaD
Fenofibrate—CYP2C8—Metabolism—ACHE—prostate cancer	5.38e-06	6.56e-05	CbGpPWpGaD
Fenofibrate—CYP2C8—Metabolism—CYP2A6—prostate cancer	5.32e-06	6.48e-05	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism—P4HB—prostate cancer	5.31e-06	6.47e-05	CbGpPWpGaD
Fenofibrate—CYP2C8—Metabolism of lipids and lipoproteins—CREBBP—prostate cancer	5.3e-06	6.46e-05	CbGpPWpGaD
Fenofibrate—CYP3A4—Metabolism—MTAP—prostate cancer	5.28e-06	6.45e-05	CbGpPWpGaD
Fenofibrate—CYP3A4—Metabolism—CYP7B1—prostate cancer	5.28e-06	6.45e-05	CbGpPWpGaD
Fenofibrate—PPARA—Metabolism—PTEN—prostate cancer	5.19e-06	6.34e-05	CbGpPWpGaD
Fenofibrate—CYP2C8—Metabolism—AKR1C3—prostate cancer	5.17e-06	6.31e-05	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism—SLC22A1—prostate cancer	5.16e-06	6.3e-05	CbGpPWpGaD
Fenofibrate—CYP3A4—Metabolism—SRD5A1—prostate cancer	5.15e-06	6.28e-05	CbGpPWpGaD
Fenofibrate—CYP3A4—Metabolism—SULT1E1—prostate cancer	5.15e-06	6.28e-05	CbGpPWpGaD
Fenofibrate—CYP2C8—Metabolism—PRKACB—prostate cancer	5.14e-06	6.27e-05	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—prostate cancer	5.1e-06	6.22e-05	CbGpPWpGaD
Fenofibrate—CYP2C8—Metabolism—CYP17A1—prostate cancer	5.09e-06	6.21e-05	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism—SULT2A1—prostate cancer	5.03e-06	6.14e-05	CbGpPWpGaD
Fenofibrate—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CD—prostate cancer	5.02e-06	6.12e-05	CbGpPWpGaD
Fenofibrate—PPARA—Metabolism—EP300—prostate cancer	4.95e-06	6.04e-05	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism—MED12—prostate cancer	4.95e-06	6.04e-05	CbGpPWpGaD
Fenofibrate—CYP3A4—Metabolism—HSD17B3—prostate cancer	4.91e-06	5.99e-05	CbGpPWpGaD
Fenofibrate—CYP3A4—Metabolism—ACSL4—prostate cancer	4.91e-06	5.99e-05	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism—GNG5—prostate cancer	4.91e-06	5.99e-05	CbGpPWpGaD
Fenofibrate—CYP2C8—Metabolism—NCOA2—prostate cancer	4.85e-06	5.92e-05	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism—NCOA3—prostate cancer	4.73e-06	5.77e-05	CbGpPWpGaD
Fenofibrate—CYP3A4—Metabolism—ARG2—prostate cancer	4.71e-06	5.74e-05	CbGpPWpGaD
Fenofibrate—CYP3A4—Metabolism—UMPS—prostate cancer	4.71e-06	5.74e-05	CbGpPWpGaD
Fenofibrate—CYP3A4—Metabolism—PHGDH—prostate cancer	4.71e-06	5.74e-05	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—prostate cancer	4.65e-06	5.67e-05	CbGpPWpGaD
Fenofibrate—CYP2C8—Metabolism—SLC5A5—prostate cancer	4.63e-06	5.64e-05	CbGpPWpGaD
Fenofibrate—CYP3A4—Metabolism—LDHB—prostate cancer	4.62e-06	5.63e-05	CbGpPWpGaD
Fenofibrate—CYP3A4—Metabolism—CYP3A5—prostate cancer	4.53e-06	5.53e-05	CbGpPWpGaD
Fenofibrate—CYP2C8—Metabolism—CYP2E1—prostate cancer	4.52e-06	5.51e-05	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism—HPGDS—prostate cancer	4.51e-06	5.5e-05	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism—CYP2C19—prostate cancer	4.49e-06	5.47e-05	CbGpPWpGaD
Fenofibrate—CYP2C8—Metabolism—NQO1—prostate cancer	4.47e-06	5.45e-05	CbGpPWpGaD
Fenofibrate—CYP2C8—Metabolism—TH—prostate cancer	4.41e-06	5.37e-05	CbGpPWpGaD
Fenofibrate—CYP3A4—Metabolism—TCN2—prostate cancer	4.38e-06	5.34e-05	CbGpPWpGaD
Fenofibrate—CYP3A4—Metabolism—PDHA1—prostate cancer	4.38e-06	5.34e-05	CbGpPWpGaD
Fenofibrate—CYP3A4—Metabolism—UCP3—prostate cancer	4.38e-06	5.34e-05	CbGpPWpGaD
Fenofibrate—CYP3A4—Metabolism—GSTA3—prostate cancer	4.38e-06	5.34e-05	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism—GSTT1—prostate cancer	4.38e-06	5.34e-05	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism—ACHE—prostate cancer	4.38e-06	5.34e-05	CbGpPWpGaD
Fenofibrate—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—prostate cancer	4.38e-06	5.34e-05	CbGpPWpGaD
Fenofibrate—CYP2C8—Metabolism—CYP3A4—prostate cancer	4.36e-06	5.32e-05	CbGpPWpGaD
Fenofibrate—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—prostate cancer	4.34e-06	5.29e-05	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism—CYP2A6—prostate cancer	4.33e-06	5.28e-05	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—prostate cancer	4.31e-06	5.26e-05	CbGpPWpGaD
Fenofibrate—CYP2C8—Metabolism—CYP1B1—prostate cancer	4.29e-06	5.23e-05	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism—AKR1C3—prostate cancer	4.21e-06	5.13e-05	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism—PRKACB—prostate cancer	4.19e-06	5.11e-05	CbGpPWpGaD
Fenofibrate—CYP3A4—Metabolism—HSD3B1—prostate cancer	4.18e-06	5.09e-05	CbGpPWpGaD
Fenofibrate—CYP3A4—Metabolism—SLC22A3—prostate cancer	4.18e-06	5.09e-05	CbGpPWpGaD
Fenofibrate—CYP2C8—Metabolism—GGT1—prostate cancer	4.15e-06	5.06e-05	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism—CYP17A1—prostate cancer	4.14e-06	5.05e-05	CbGpPWpGaD
Fenofibrate—CYP2C8—Metabolism—NCOA1—prostate cancer	4.09e-06	4.99e-05	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—prostate cancer	4.09e-06	4.98e-05	CbGpPWpGaD
Fenofibrate—CYP2C8—Metabolism—CYP19A1—prostate cancer	4.03e-06	4.91e-05	CbGpPWpGaD
Fenofibrate—CYP3A4—Metabolism—GSTA4—prostate cancer	4.01e-06	4.88e-05	CbGpPWpGaD
Fenofibrate—CYP3A4—Metabolism—TBXAS1—prostate cancer	4.01e-06	4.88e-05	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism—NCOA2—prostate cancer	3.95e-06	4.82e-05	CbGpPWpGaD
Fenofibrate—CYP3A4—Metabolism—GSTA2—prostate cancer	3.9e-06	4.76e-05	CbGpPWpGaD
Fenofibrate—CYP2C8—Metabolism—RXRA—prostate cancer	3.89e-06	4.74e-05	CbGpPWpGaD
Fenofibrate—CYP3A4—Metabolism—ABCG5—prostate cancer	3.86e-06	4.7e-05	CbGpPWpGaD
Fenofibrate—CYP3A4—Metabolism—SULT1A1—prostate cancer	3.86e-06	4.7e-05	CbGpPWpGaD
Fenofibrate—PPARA—Gene Expression—AKT1—prostate cancer	3.85e-06	4.7e-05	CbGpPWpGaD
Fenofibrate—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	3.78e-06	4.61e-05	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism—SLC5A5—prostate cancer	3.77e-06	4.59e-05	CbGpPWpGaD
Fenofibrate—CYP3A4—Metabolism—GSTA1—prostate cancer	3.77e-06	4.59e-05	CbGpPWpGaD
Fenofibrate—CYP2C8—Metabolism—COMT—prostate cancer	3.75e-06	4.57e-05	CbGpPWpGaD
Fenofibrate—CYP2C8—Metabolism—GSTP1—prostate cancer	3.73e-06	4.55e-05	CbGpPWpGaD
Fenofibrate—CYP3A4—Metabolism—HSD3B2—prostate cancer	3.72e-06	4.54e-05	CbGpPWpGaD
Fenofibrate—CYP3A4—Metabolism—NAT2—prostate cancer	3.72e-06	4.54e-05	CbGpPWpGaD
Fenofibrate—CYP3A4—Metabolism—GSTO1—prostate cancer	3.72e-06	4.54e-05	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism—CYP2E1—prostate cancer	3.68e-06	4.49e-05	CbGpPWpGaD
Fenofibrate—CYP2C8—Metabolism—ITPR1—prostate cancer	3.67e-06	4.47e-05	CbGpPWpGaD
Fenofibrate—PPARA—Metabolism—PIK3CA—prostate cancer	3.66e-06	4.47e-05	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism—NQO1—prostate cancer	3.64e-06	4.44e-05	CbGpPWpGaD
Fenofibrate—CYP2C8—Metabolism of lipids and lipoproteins—EP300—prostate cancer	3.61e-06	4.4e-05	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism—TH—prostate cancer	3.59e-06	4.37e-05	CbGpPWpGaD
Fenofibrate—CYP3A4—Metabolism—PLCB2—prostate cancer	3.57e-06	4.35e-05	CbGpPWpGaD
Fenofibrate—CYP3A4—Metabolism—LRP2—prostate cancer	3.57e-06	4.35e-05	CbGpPWpGaD
Fenofibrate—CYP3A4—Metabolism—CYP2C18—prostate cancer	3.57e-06	4.35e-05	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—prostate cancer	3.56e-06	4.34e-05	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism—CYP3A4—prostate cancer	3.55e-06	4.33e-05	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—prostate cancer	3.53e-06	4.3e-05	CbGpPWpGaD
Fenofibrate—CYP3A4—Metabolism—P4HB—prostate cancer	3.5e-06	4.27e-05	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism—CYP1B1—prostate cancer	3.49e-06	4.25e-05	CbGpPWpGaD
Fenofibrate—CYP2C8—Metabolism—TYMS—prostate cancer	3.47e-06	4.23e-05	CbGpPWpGaD
Fenofibrate—CYP2C8—Metabolism—GSTM1—prostate cancer	3.43e-06	4.18e-05	CbGpPWpGaD
Fenofibrate—CYP3A4—Metabolism—SLC22A1—prostate cancer	3.41e-06	4.15e-05	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism—GGT1—prostate cancer	3.38e-06	4.12e-05	CbGpPWpGaD
Fenofibrate—CYP2C8—Metabolism—LPL—prostate cancer	3.36e-06	4.1e-05	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism—NCOA1—prostate cancer	3.33e-06	4.06e-05	CbGpPWpGaD
Fenofibrate—CYP3A4—Metabolism—SULT2A1—prostate cancer	3.32e-06	4.05e-05	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism—CYP19A1—prostate cancer	3.28e-06	4e-05	CbGpPWpGaD
Fenofibrate—CYP3A4—Metabolism—MED12—prostate cancer	3.27e-06	3.98e-05	CbGpPWpGaD
Fenofibrate—CYP2C8—Metabolism—CYP1A1—prostate cancer	3.25e-06	3.96e-05	CbGpPWpGaD
Fenofibrate—CYP3A4—Metabolism—GNG5—prostate cancer	3.24e-06	3.95e-05	CbGpPWpGaD
Fenofibrate—CYP2C8—Metabolism—ERCC2—prostate cancer	3.22e-06	3.93e-05	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism—RXRA—prostate cancer	3.17e-06	3.86e-05	CbGpPWpGaD
Fenofibrate—CYP3A4—Metabolism—NCOA3—prostate cancer	3.12e-06	3.81e-05	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	3.08e-06	3.75e-05	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism—COMT—prostate cancer	3.05e-06	3.72e-05	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism—GSTP1—prostate cancer	3.03e-06	3.7e-05	CbGpPWpGaD
Fenofibrate—CYP2C8—Metabolism—MTHFR—prostate cancer	3.03e-06	3.69e-05	CbGpPWpGaD
Fenofibrate—PPARA—Metabolism—AKT1—prostate cancer	2.99e-06	3.65e-05	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism—ITPR1—prostate cancer	2.99e-06	3.64e-05	CbGpPWpGaD
Fenofibrate—CYP3A4—Metabolism—HPGDS—prostate cancer	2.98e-06	3.63e-05	CbGpPWpGaD
Fenofibrate—CYP2C8—Metabolism—PPARA—prostate cancer	2.97e-06	3.62e-05	CbGpPWpGaD
Fenofibrate—CYP3A4—Metabolism—CYP2C19—prostate cancer	2.96e-06	3.61e-05	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism of lipids and lipoproteins—EP300—prostate cancer	2.94e-06	3.58e-05	CbGpPWpGaD
Fenofibrate—CYP3A4—Metabolism—GSTT1—prostate cancer	2.89e-06	3.52e-05	CbGpPWpGaD
Fenofibrate—CYP3A4—Metabolism—ACHE—prostate cancer	2.89e-06	3.52e-05	CbGpPWpGaD
Fenofibrate—CYP3A4—Metabolism—CYP2A6—prostate cancer	2.85e-06	3.48e-05	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism—TYMS—prostate cancer	2.82e-06	3.44e-05	CbGpPWpGaD
Fenofibrate—CYP2C8—Metabolism—CAV1—prostate cancer	2.79e-06	3.41e-05	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism—GSTM1—prostate cancer	2.79e-06	3.4e-05	CbGpPWpGaD
Fenofibrate—CYP3A4—Metabolism—AKR1C3—prostate cancer	2.78e-06	3.39e-05	CbGpPWpGaD
Fenofibrate—CYP3A4—Metabolism—PRKACB—prostate cancer	2.76e-06	3.37e-05	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism—LPL—prostate cancer	2.74e-06	3.34e-05	CbGpPWpGaD
Fenofibrate—CYP3A4—Metabolism—CYP17A1—prostate cancer	2.73e-06	3.33e-05	CbGpPWpGaD
Fenofibrate—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	2.67e-06	3.25e-05	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism—CYP1A1—prostate cancer	2.64e-06	3.22e-05	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism—ERCC2—prostate cancer	2.62e-06	3.2e-05	CbGpPWpGaD
Fenofibrate—CYP3A4—Metabolism—NCOA2—prostate cancer	2.6e-06	3.18e-05	CbGpPWpGaD
Fenofibrate—CYP2C8—Metabolism—PIK3CG—prostate cancer	2.54e-06	3.1e-05	CbGpPWpGaD
Fenofibrate—CYP3A4—Metabolism—SLC5A5—prostate cancer	2.48e-06	3.03e-05	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism—MTHFR—prostate cancer	2.46e-06	3.01e-05	CbGpPWpGaD
Fenofibrate—CYP3A4—Metabolism—CYP2E1—prostate cancer	2.43e-06	2.96e-05	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism—PPARA—prostate cancer	2.42e-06	2.95e-05	CbGpPWpGaD
Fenofibrate—CYP2C8—Metabolism—INS—prostate cancer	2.41e-06	2.94e-05	CbGpPWpGaD
Fenofibrate—CYP3A4—Metabolism—NQO1—prostate cancer	2.4e-06	2.93e-05	CbGpPWpGaD
Fenofibrate—CYP3A4—Metabolism—TH—prostate cancer	2.36e-06	2.88e-05	CbGpPWpGaD
Fenofibrate—CYP2C8—Metabolism—CREBBP—prostate cancer	2.36e-06	2.88e-05	CbGpPWpGaD
Fenofibrate—CYP3A4—Metabolism—CYP1B1—prostate cancer	2.3e-06	2.81e-05	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism—CAV1—prostate cancer	2.27e-06	2.77e-05	CbGpPWpGaD
Fenofibrate—CYP2C8—Metabolism—PIK3CD—prostate cancer	2.24e-06	2.73e-05	CbGpPWpGaD
Fenofibrate—CYP3A4—Metabolism—GGT1—prostate cancer	2.23e-06	2.72e-05	CbGpPWpGaD
Fenofibrate—CYP3A4—Metabolism—NCOA1—prostate cancer	2.19e-06	2.68e-05	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	2.17e-06	2.65e-05	CbGpPWpGaD
Fenofibrate—CYP3A4—Metabolism—CYP19A1—prostate cancer	2.16e-06	2.64e-05	CbGpPWpGaD
Fenofibrate—CYP2C8—Metabolism—NOS3—prostate cancer	2.11e-06	2.58e-05	CbGpPWpGaD
Fenofibrate—CYP3A4—Metabolism—RXRA—prostate cancer	2.09e-06	2.55e-05	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism—PIK3CG—prostate cancer	2.07e-06	2.53e-05	CbGpPWpGaD
Fenofibrate—CYP3A4—Metabolism—COMT—prostate cancer	2.01e-06	2.45e-05	CbGpPWpGaD
Fenofibrate—CYP3A4—Metabolism—GSTP1—prostate cancer	2e-06	2.44e-05	CbGpPWpGaD
Fenofibrate—CYP3A4—Metabolism—ITPR1—prostate cancer	1.97e-06	2.4e-05	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism—INS—prostate cancer	1.96e-06	2.39e-05	CbGpPWpGaD
Fenofibrate—CYP2C8—Metabolism—PIK3CB—prostate cancer	1.95e-06	2.38e-05	CbGpPWpGaD
Fenofibrate—CYP2C8—Metabolism—PTGS2—prostate cancer	1.93e-06	2.36e-05	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism—CREBBP—prostate cancer	1.92e-06	2.34e-05	CbGpPWpGaD
Fenofibrate—CYP3A4—Metabolism—TYMS—prostate cancer	1.86e-06	2.27e-05	CbGpPWpGaD
Fenofibrate—CYP3A4—Metabolism—GSTM1—prostate cancer	1.84e-06	2.24e-05	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism—PIK3CD—prostate cancer	1.82e-06	2.22e-05	CbGpPWpGaD
Fenofibrate—CYP3A4—Metabolism—LPL—prostate cancer	1.81e-06	2.2e-05	CbGpPWpGaD
Fenofibrate—CYP3A4—Metabolism—CYP1A1—prostate cancer	1.74e-06	2.13e-05	CbGpPWpGaD
Fenofibrate—CYP3A4—Metabolism—ERCC2—prostate cancer	1.73e-06	2.11e-05	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism—NOS3—prostate cancer	1.72e-06	2.1e-05	CbGpPWpGaD
Fenofibrate—CYP2C8—Metabolism—PTEN—prostate cancer	1.68e-06	2.05e-05	CbGpPWpGaD
Fenofibrate—CYP3A4—Metabolism—MTHFR—prostate cancer	1.63e-06	1.98e-05	CbGpPWpGaD
Fenofibrate—CYP2C8—Metabolism—EP300—prostate cancer	1.61e-06	1.96e-05	CbGpPWpGaD
Fenofibrate—CYP3A4—Metabolism—PPARA—prostate cancer	1.59e-06	1.94e-05	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism—PIK3CB—prostate cancer	1.59e-06	1.93e-05	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism—PTGS2—prostate cancer	1.57e-06	1.92e-05	CbGpPWpGaD
Fenofibrate—CYP3A4—Metabolism—CAV1—prostate cancer	1.5e-06	1.83e-05	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism—PTEN—prostate cancer	1.37e-06	1.67e-05	CbGpPWpGaD
Fenofibrate—CYP3A4—Metabolism—PIK3CG—prostate cancer	1.37e-06	1.67e-05	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism—EP300—prostate cancer	1.31e-06	1.59e-05	CbGpPWpGaD
Fenofibrate—CYP3A4—Metabolism—INS—prostate cancer	1.29e-06	1.58e-05	CbGpPWpGaD
Fenofibrate—CYP3A4—Metabolism—CREBBP—prostate cancer	1.27e-06	1.54e-05	CbGpPWpGaD
Fenofibrate—CYP3A4—Metabolism—PIK3CD—prostate cancer	1.2e-06	1.46e-05	CbGpPWpGaD
Fenofibrate—CYP2C8—Metabolism—PIK3CA—prostate cancer	1.19e-06	1.45e-05	CbGpPWpGaD
Fenofibrate—CYP3A4—Metabolism—NOS3—prostate cancer	1.13e-06	1.38e-05	CbGpPWpGaD
Fenofibrate—CYP3A4—Metabolism—PIK3CB—prostate cancer	1.05e-06	1.28e-05	CbGpPWpGaD
Fenofibrate—CYP3A4—Metabolism—PTGS2—prostate cancer	1.04e-06	1.26e-05	CbGpPWpGaD
Fenofibrate—CYP2C8—Metabolism—AKT1—prostate cancer	9.71e-07	1.18e-05	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism—PIK3CA—prostate cancer	9.67e-07	1.18e-05	CbGpPWpGaD
Fenofibrate—CYP3A4—Metabolism—PTEN—prostate cancer	9.04e-07	1.1e-05	CbGpPWpGaD
Fenofibrate—CYP3A4—Metabolism—EP300—prostate cancer	8.62e-07	1.05e-05	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism—AKT1—prostate cancer	7.9e-07	9.64e-06	CbGpPWpGaD
Fenofibrate—CYP3A4—Metabolism—PIK3CA—prostate cancer	6.38e-07	7.78e-06	CbGpPWpGaD
Fenofibrate—CYP3A4—Metabolism—AKT1—prostate cancer	5.21e-07	6.35e-06	CbGpPWpGaD
